Health care biotech companies by one-year price change
How far the share price has moved over the last 52 weeks.
Moderna leads the 24 health care biotech companies ranked by one-year price change, at +780%, ahead of Kodiak Sciences (+399%) and Twist Bioscience (+346%). Figures as of 19 Nov 2026, 15:48 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Moderna+780%
- Median
- +42.2%
- Combined market value
- AED 3.03T
- Countries
- 5
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ModernaMRNA · Health Care | +780% | AED 289.5B | AED 715.39 | 1.02% down | 780% up | ||
| 2 | Kodiak SciencesKOD · Health Care | +399% | AED 23.2B | AED 354.32 | 1.37% down | 399% up | ||
| 3 | Twist BioscienceTWST · Health Care | +346% | AED 29.9B | AED 438.47 | 2.60% up | 346% up | ||
| 4 | ImmunityBioIBRX · Health Care | +232% | AED 25.3B | AED 23.80 | 3.28% down | 232% up | ||
| 5 | Revolution MedicinesRVMD · Health Care | +129% | AED 129.3B | AED 597.80 | 1.84% up | 129% up | ||
| 6 | CG OncologyCGON · Health Care | +96.5% | AED 26.7B | AED 299.34 | 1.88% up | 97% up | ||
| 7 | Kymera TherapeuticsKYMR · Health Care | +87.4% | AED 37.3B | AED 436.67 | 1.85% down | 87% up | ||
| 8 | Adaptive BiotechnologiesADPT · Health Care | +74.4% | AED 17.1B | AED 105.74 | 1.16% up | 74% up | ||
| 9 | ExelixisEXEL · Health Care | +63.5% | AED 58.9B | AED 241.24 | 3.82% down | 63% up | ||
| 10 | Krystal BiotechKRYS · Health Care | +54.4% | AED 34.3B | AED 1,156.12 | 0.18% down | 54% up | ||
| 11 | BiogenBIIB · Health Care | +49.5% | AED 133.7B | AED 904.58 | 2.04% down | 49% up | ||
| 12 | ImmunovantIMVT · Health Care | +45.5% | AED 25B | AED 120.58 | 1.03% down | 46% up | ||
| 13 | Halozyme TherapeuticsHALO · Health Care | +38.9% | AED 38.3B | AED 336.22 | 4.45% down | 39% up | ||
| 14 | Gilead SciencesGILD · Health Care | +35.2% | AED 753.4B | AED 607.44 | 2.13% down | 35% up | ||
| 15 | AmgenAMGN · Health Care | +32.1% | AED 867.3B | AED 1,603.33 | 1.66% down | 32% up | ||
| 16 | Scholar Rock HoldingSRRK · Health Care | +26.2% | AED 22B | AED 180.60 | 2.44% up | 26% up | ||
| 17 | Bio-TechneTECH · Health Care | +23.9% | AED 42B | AED 267.09 | 0.04% down | 24% up | ||
| 18 | VaxcytePCVX · Health Care | +22.8% | AED 34.3B | AED 216.61 | 0.78% up | 23% up | ||
| 19 | Neurocrine BiosciencesNBIX · Health Care | +17.2% | AED 58.9B | AED 581.97 | 2.71% down | 17% up | ||
| 20 | RepligenRGEN · Health Care | +11.9% | AED 41.4B | AED 646.87 | 2.00% up | 12% up | ||
| 21 | QiagenQGEN · Health Care | +8.52% | AED 37.7B | AED 182.43 | 0.22% up | 9% up | ||
| 22 | argenxARGX · Health Care | +2.48% | AED 216.1B | AED 3,436.00 | 0.61% down | 2% up | ||
| 23 | BioNTechBNTX · Health Care | -14.1% | AED 74.7B | AED 301.10 | 1.54% down | 14% down | ||
| 24 | CRISPR TherapeuticsCRSP · Health Care | -18.5% | AED 14.4B | AED 148.20 | 0.40% up | 18% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6729 AED).
Questions and answers
Which health care biotech companies rank first by one-year price change?
Moderna (+780%), Kodiak Sciences (+399%) and Twist Bioscience (+346%) are the top three of the 24 health care biotech companies ranked by one-year price change as of 19 Nov 2026, 15:48 UTC.
How many health care biotech companies are in this ranking?
24 are ranked by one-year price change.
What are these health care biotech companies worth together?
The 24 health care biotech companies ranked by one-year price change have a combined market value of AED 3.03T as of 19 Nov 2026, 15:48 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care biotech companies by one-year price change”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.